NT Pharma Schedules 4 June 2026 AGM; Proposes 20% Issuance Mandate, 10% Buy-back Limit and HK$0.75–0.85 Million Audit Fee

Bulletin Express
04/30

China NT Pharma Group Company Limited (NT Pharma) has issued its circular for the 2026 annual general meeting (AGM), to be held on 4 June 2026 at 11:00 a.m. in Hong Kong. Key proposals to be put to shareholders include fresh mandates for share issuance and repurchase, the re-election of three directors and the re-appointment of the external auditor.

Mandates for Share Issuance and Repurchase • Issuance mandate: The board seeks authority to allot and issue up to 20% of the company’s issued share capital as of the AGM date. Based on the current 948.99 million shares in issue, the mandate would allow up to 189.80 million new shares. • Repurchase mandate: A parallel resolution authorises the company to buy back up to 10% of issued shares, equating to 94.90 million shares. Any shares repurchased may be used to extend the issuance capacity, subject to regulatory limits.

Directors up for Re-election The following directors retire by rotation and offer themselves for re-election: 1. Chin Yu – Co-founder, non-executive director, holds 304.20 million shares (32.05% stake). 2. Dr. Zhao Yubiao – Independent non-executive director, annual remuneration HK$0.14 million. 3. Lou Yongbin – Non-executive director, holds 61.07 million shares (6.44% stake).

Auditor Re-appointment and Fees Moore CPA Limited is nominated for re-appointment as external auditor. The estimated audit fee for the financial year ending 31 December 2026 is HK$0.75–0.85 million, exclusive of out-of-pocket expenses and potential incremental work arising from the March 2026 acquisition of Zhejiang Kangyuan Medical Device Co.

Capital Structure and Major Shareholders As of 23 April 2026, NT Pharma’s issued share capital totals 948.99 million ordinary shares. Major shareholders include: • Ng Tit and Chin Yu, jointly controlling 304.20 million shares (32.05%). • Ieong Iat with 146.52 million shares (15.44%). • Chen HongLi with 80.33 million shares (8.46%). • Zhang GenHuo with 79.40 million shares (8.37%). The company confirms that any share repurchases will be conducted within the 25% public-float requirement.

Logistics and Voting Shareholders must lodge proxy forms with Tricor Investor Services by 2 June 2026. All AGM resolutions will be decided by poll. The register of members will close from 1 June to 4 June 2026, inclusive.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10